Skip to main content
SpringerLink
Log in

Pharmacokinetic and Pharmacoimmunodynamic Interactions Between Prednisolone and Sirolimus in Adrenalectomized Rats

  • Published:
Journal of Pharmacokinetics and Biopharmaceutics Aims and scope Submit manuscript

Abstract

Prednisolone (Pred) and sirolimus (SIR) are immunosuppressive compounds acting through different mechanisms with moderate synergism found in vitro. Both drugs are metabolized partly by CYP3A enzymes. After iv administration of placebo, Pred (5 mg/kg), SIR (1 mg/kg), or Pred with SIR (5 and 1 mg/kg doses) to adrenalectomized male rats, Pred plasma and SIR whole blood concentrations were followed for 48 hr along with circulating T-helper and T-cytotoxic cell counts. Ex vivo whole blood lymphocyte proliferation marked host responsiveness. An extended indirect PK/PD model was used to describe responses to these drugs, alone or combined. An interactive two-stage population analysis showed no modification in drug PK. Mean Pred plasma clearance was 0.655 L/hr (interrat variability: 11%) and significantly increased with weight. Mean SIR whole blood volume of distribution and clearance were 5.6 L (62%) and 0.28 L/hr (32%), and animal scaling showed weight power proportionality. In vitro metabolism studies showed no significant inhibition of Pred or prednisone CYP3A metabolism by SIR (50 μM), but this pathway accounted for less than 5% of Pred metabolism. Pred decreased numbers of T-helper lymphocytes with a mean IC50 of 37.8 nM (21%) alone or 12.3 nM (130%) with SIR. Results for T-cytotoxic lymphocytes were similar. SIR increased lymphocyte numbers with a mean IC50 of 52.2 nM (24%) for T-helper and 28.8 nM (51%) for T-cytotoxic cells. Taking into account drug effects on lymphocyte trafficking, Pred directly inhibited ex vivo lymphocyte proliferation with a mean IC50 of 1.08 nM (38%). SIR, after a transduction step, inhibited proliferation with a mean IC50 of 1.00 nM (26%). Responses measured after drug coadministration were reasonably quantitated by addition of single drug effects. Since, at pharmacologic concentrations in rats, Pred and SIR did not interact in their PK but synergistically or additively interact in their dynamics, their joint therapeutic use is promising. The adrenalectomized rat may be a suitable animal model to characterize drug effects on lymphocyte trafficking and reactivity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. A. S. Shoker. Immunopharmacologic therapy in renal transplantation. Pharmacotherapy 16:562–575 (1996).

    CAS  PubMed  Google Scholar 

  2. R. Morris, Rapamycins: Antifungal, antitumor, antiproliferative, and immunosuppressive macrolides. Transpl. Rev. 6:39–87 (1992).

    Article  Google Scholar 

  3. A. S. Fauci, D. C. Dale, and J. E. Balow. Glucocorticosteroid therapy: Mechanism of action and clinical considerations. Ann. Intern. Med. 84:304–315 (1976).

    Article  CAS  PubMed  Google Scholar 

  4. E. Bloemena, S. Weinreich, and P. T. A. Schellekens. The influence of prednisolone on the recirculation of peripheral blood lymphocytes in vivo. Clin. Exp. Immunol. 80:460–466 (1990).

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  5. M. Scudeletti, L. Castagnetta, B. Imbimbo, F. Puppo, I. Pierri, and F. Indiveri. New glucocorticoids: Mechanisms of immunological activity at the cellular level and in the clinical setting. Ann. N.Y. Acad. Sci. 595:368–382 (1990).

    Article  CAS  PubMed  Google Scholar 

  6. M. G. Murgia, S. Jordan, and B. Kahan. The side effect profile of sirolimus: a phase I study in quiescent cyclosporin-prednisone-treated renal transplant patients. Kidney Int. 49:209–216 (1996).

    Article  CAS  PubMed  Google Scholar 

  7. D. E. Hricik, W. Y. Almawi, and T. B. Strom. Trends in the use of glucocorticoids in renal transplantation. Transplantation 57:979–989 (1994).

    Article  CAS  PubMed  Google Scholar 

  8. G. Schmidbauer, W. W. Hancock, B. Wasowska, A. M. Badger, and J. W. Kupiec-Weglinski. Abrogation by rapamycin of accelerated rejection in sensitized rats by inhibition of alloantibody responses and selective suppression of intragraft mononuclear and endothelial cell activation, cytokine production, and cell adhesion. Transplantation 57:933–941 (1994).

    Article  CAS  PubMed  Google Scholar 

  9. G. M. Ferron and W. J. Jusko. Species-and gender-related differences in cyclosporine/prednisolone/sirolimus interactions in whole blood lymphocyte proliferation assays. J. Pharmacol. Exp. Ther. 286:191–200 (1998).

    CAS  PubMed  Google Scholar 

  10. M. Sattler, P. Guengerich, C.-H. Yun, U. Christians, and K.-F. Sewing. Cytochrome P450 3A enzymes are responsible for biotransformation of FK506 and rapamycin in man and rat. Drug Metab. Dispos. 20:753–761 (1992).

    CAS  PubMed  Google Scholar 

  11. F. J. Frey and B. M. Frey. Urinary 6β-hydroxyprednisolone excretion indicates enhanced prednisolone catabolism. J. Lab. Clin. Med. 101:593–604 (1983).

    CAS  PubMed  Google Scholar 

  12. I. A. Shah, P. H. Whiting, G. Omar, A. W. Thomson, and M. D. Burke. Effects of FK506 on human hepatic microsomal cytochrome P-450-dependent drug metabolism in vitro. Transpl. Proc. 23:2783–2785 (1991).

    CAS  Google Scholar 

  13. Y. M. Ning and E. R. Sanchez. Potentiation of glucocorticoid receptor-mediated gene expression by the immunophilin ligands FK506 and rapamycin. J. Biol. Chem. 268:6073–6076 (1993).

    CAS  PubMed  Google Scholar 

  14. Y. M. Ning and E. R. Sanchez. Stabilization in vitro of the untransformed glucocorticoid receptor complex of S49 lymphocytes by the immunophilin ligand FK506. J. Steroid Molec. Biol. 52:187–194 (1994).

    Article  Google Scholar 

  15. Y. M. Ning and E. R. Sanchez. Immunophilins, heat shock proteins, and glucocorticoid receptor actions in vivo. Methods. 9:188–200 (1996).

    Article  PubMed  Google Scholar 

  16. G. Powis, I. Jardine, R. Van Dyke, R. Weinshilboum, D. Moore, T. Wilke, W. Rhodes, R. Nelson, L. Benson, and C. Szumlanski. Foreign compound metabolism studies with human liver obtained as surgical waste. Relation to donor characteristics and effects of tissue storage. Drug Metab. Disp. 16:582–589 (1988).

    CAS  Google Scholar 

  17. W. J. Jusko, N. A. Pyszcynski, M. S. Bushway, R. D'Ambrosio, and S. M. Mis. Fifteen years of operation of high-performance liquid chromatographic assay for prednisolone, cortisol and prednisone in plasma. J. Chromatog. B. 658:47–54 (1994).

    Article  CAS  Google Scholar 

  18. G. M. Ferron, W. D. Conway, and W. J. Jusko. Lipophilic benzamide and anilide derivatives as high-performance liquid chromatography internal standards: application to sirolimus (rapamycin) determination. J. Chromatog. B 703:243–251 (1997).

    Article  CAS  Google Scholar 

  19. V. Garg and W. J. Jusko. Bioavailability and reversible metabolism of prednisone and prednisolone in man. Biopharm. Drug Disp. 15:163–172 (1994).

    Article  CAS  Google Scholar 

  20. V. G. Hale and L. Z. Benet. Prednisolone and prednisone exhibit linear extraction in the perfused rabbit liver. Drug Metab. Disp. 19:87–93 (1991).

    CAS  Google Scholar 

  21. R. Murata, D. B. Haughey, and W. J. Jusko. Effects of thyroid dysfunction on prednisolone and prednisone interconversion and disposition in the rat. Drug Metab. Disp. 18:403–408 (1990).

    CAS  Google Scholar 

  22. S. M. Abel, J. L. Maggs, D. J. Back, and B. K. Park. Cortisol metabolism by human liver in vitro—I. Metabolite identification and inter-individual variability. J. Steroid Biochem. Molec. Biol. 43:713–719 (1992).

    Article  CAS  PubMed  Google Scholar 

  23. Y.-N. Sun and W. J. Jusko. Transit compartments versus gamma distribution function to model signal transduction processes in pharmacodynamics, J. Pharm. Sci. 87:732–737 (1998).

    Article  CAS  PubMed  Google Scholar 

  24. R. Yatscoff, D. LeGatt, R. Keenan, and P. Chackowsky. Blood distribution of rapamycin. Transplantation 56:1202–1206 (1993).

    Article  CAS  PubMed  Google Scholar 

  25. J. Mordenti. Man versus beast: pharmacokinetic scaling in mammals. J Pharm. Sci. 11:1028–1040 (1986).

    Article  Google Scholar 

  26. J.-L. Steimer, A. Mallet, J.-L. Golmard, and J.-F. Boisvieux. Alternative approaches to estimation of population pharmacokinetic parameters: comparison with the NONlinear Mixed-Effect Model. Drug Metab. Rev. 15:265–292 (1984).

    Article  CAS  PubMed  Google Scholar 

  27. A. Nichols, R. D'Ambrosio, N. A. Pyszczynski, and W. J. Jusko. Pharmacokinetics and pharmacodynamics of prednisolone in obese rats. J. Pharmacol. Exp. Ther. 250:963–970 (1989).

    CAS  PubMed  Google Scholar 

  28. F. D. Boudinot and W. J. Jusko. Dose-dependent pharmacokinetics of prednisolone in normal and adrenalectomized rats. J. Pharmacokin. Biopharm. 14:453–467 (1986).

    Article  CAS  Google Scholar 

  29. G. M. Ferron and W. J. Jusko. Species differences in sirolimus stability in humans, rabbits and rats. Drug Metab. Dispos. 26:83–84 (1998).

    CAS  PubMed  Google Scholar 

  30. F. S. Chow, W. Piekoszewski, and W. J. Jusko. Effect of hematocrit and albumin concentration on hepatic clearance of tacrolimus (FK506) during rabbit liver perfusion. Drug Metab. Dispos. 25:610–616 (1997).

    CAS  PubMed  Google Scholar 

  31. N. Honcharik, J. Fryer, and R. Yatscoff. Pharmacokinetics of rapamycin: Single-dose studies in the rabbit. Ther. Drug Monit. 14:475–478 (1992).

    Article  CAS  PubMed  Google Scholar 

  32. R. W. Yatscoff, P. Wang, K. Chan, D. Hicks, and J. J. Zimmerman. Rapamycin: Distribution, pharmacokinetics and therapeutic range investigations. Ther. Drug Monit. 17:666–671 (1995).

    Article  CAS  PubMed  Google Scholar 

  33. G. M. Ferron, E. V. Mishina, J. J. Zimmerman, and W. J. Jusko. Population pharmacokinetics of sirolimus in kidney transplant patients. Clin. Pharmacol. Ther. 61:416–428 (1997).

    Article  CAS  PubMed  Google Scholar 

  34. A. Gascon, B. Calvo, R. M. Hernandez, A. Dominguez-Gil, and J.-L. Pedraz. Interspecies scaling of cimetidine-theophylline pharmacokinetic interaction: Interspecies scaling in pharmacokinetic interactions. Pharm. Res. 11:495 (1994).

    Article  Google Scholar 

  35. W. J. Jusko, G. M. Ferron, S. M. Mis, B. D. Kahan, and J. J. Zimmerman. Pharmacokinetics of prednisolone during administration of sirolimus in patients with renal transplants. J. Clin. Pharmacol. 36:1100–1106 (1996).

    Article  CAS  PubMed  Google Scholar 

  36. D. J. Waxman, C. Attisano, F. P. Guengerich, and D. P. Lapenson. Human liver microsomal steroid hormone 6β-hydroxylase cytochrome P-450 enzyme. Arch. Biochem. Biophys. 263:424–436 (1988).

    Article  CAS  PubMed  Google Scholar 

  37. R. M. Zürcher, B. M. Frey, and F. J. Frey. Impact of ketoconazole on the metabolism of prednisolone. Clin. Pharmacol. Ther. 45:366–372 (1989).

    Article  PubMed  Google Scholar 

  38. V. G. Hale and L. Z. Benet. The interconversion of prednisone and prednisolone in human and rabbit organs in vitro is a function of tissue integrity. Pharmacol. 44:273–282 (1992).

    Article  CAS  Google Scholar 

  39. P. Schmiedlin-Ren, D. J. Edwards, M. E. Fitzsimmons, K. He, K. S. Lown, P. M. Woster, A. Rahman, K. E. Thummel, J. M. Fisher, P. F. Hollenberg, and P. B. Watkins. Mechanisms of enhanced oral availability of CYP3A substrates by grapefruit constituents: Decreased enterocyte CYP3A concentration and mechanism-based inactivation by furanocoumarins. Drug Metab. Dispos. 25:1228–1233 (1997).

    CAS  PubMed  Google Scholar 

  40. R. Sackstein and M. Borenstein. The effects of corticosteroids on lymphocyte recirculation in humans: Analysis of the mechanism of impaired lymphocyte migration to lymph node following methylprednisolone administration. J. Invest. Med. 43:68–77 (1995).

    CAS  Google Scholar 

  41. J. Wald and W. J. Jusko. Prednisolone pharmacodynamics: Leukocyte trafficking in the rat. Life Sci. 55:371–378 (1994).

    Article  Google Scholar 

  42. M. Milad, E. A. Ludwig, S. Anne, E. Middleton, and W. J. Jusko. Pharmacodynamic model for joint exogenous and endogenous corticosteroid suppression of lymphocyte trafficking. J. Pharmacokin. Biopharm. 22:469–480 (1994).

    Article  CAS  Google Scholar 

  43. W. Piekoszewski, F. S. Chow, and W. J. Jusko. Pharmacokinetic and pharmacodynamic effects of coadministration of methylprednisolone and tacrolimus in rabbits. J. Pharmacol. Exp. Ther. 269:103–109 (1994).

    CAS  PubMed  Google Scholar 

  44. E. Bloemena, M. Roos, J. L. Van Heijst, J. M. Roosen, and P. T. A. Schellenkens. Whole-blood lymphocyte cultures. J. Immunol. Meth. 122:161–167 (1989).

    Article  CAS  Google Scholar 

  45. S. N. Sehgal. Rapamune (sirolimus, rapamycin): An overview and mechanism of action. Ther. Drug Monit. 17:660–665 (1995).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Author notes

  1. Geraldine M. Ferron

    Present address: Department of Pharmaceutics, State University of New York at Buffalo, New York

Authors and Affiliations

  1. Department of Pharmaceutics, State University of New York at Buffalo, New York

    Nancy A. Pyszczynski & William J. Jusko

Authors
  1. Geraldine M. Ferron
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nancy A. Pyszczynski
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. William J. Jusko
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ferron, G.M., Pyszczynski, N.A. & Jusko, W.J. Pharmacokinetic and Pharmacoimmunodynamic Interactions Between Prednisolone and Sirolimus in Adrenalectomized Rats. J Pharmacokinet Pharmacodyn 27, 1–21 (1999). https://doi.org/10.1023/A:1020626611479

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1020626611479

Search

Navigation